10X Genomics Inc vs Workiva Inc — how do they compare? 10X Genomics Inc trades at $47.2 (market cap $5.48B), while Workiva Inc trades at $55.02 (market cap $3.21B). The key difference: 10X Genomics Inc is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Workiva Inc nearer its low. Which is the better fit depends on your goals.
| TXG | WK | |
|---|---|---|
Market Cap | $5.48B | $3.21B |
Sector | Health | Technology |
52-Week High | $45.80 | $93.31 |
52-Week Low | $11.34 | $44.31 |
Enterprise Value | $5.02B | $3.14B |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →